After retreating from many leading biotech and emerging pharmaceutical stocks in the previous two periods, short sellers returned in early March, especially in Celgene, Medivation and Pharmacyclics.
For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from the halls of Congress hit the sector hard. This may be a perfect entry…
Zogenix has traded like a company that is about to implode. Its highly controversial Zohydro has been getting inquiries into how it was approved for marketing despite an FDA panel being against the recommendation.
Biopharmaceutical firm Versartis sold 6 million shares in a Friday morning IPO at a price higher than the estimated range. Shares were up more than 60% in the noon hour.
Endocyte is trading like it is being acquired. This is proof that any biotech with great cancer drug news can run, regardless of market conditions. One has to wonder if Endocyte is among the…
WellPoint raised its earnings outlook for the 2014 fiscal year, citing a benefit from the Affordable Care Act, aka Obamacare, and the expected addition of a million or more new members.
Mediwound offered 5 million shares in a Thursday IPO at the low end of the expected range. Akebia Therapeutics offered 5.9 million shares in its IPO at the high end of the expected price…
St. Patrick's Day may have come and gone for this year, but the analysts at biotech boutique shop Leerink have highlighted six Ireland-based firms that could be tempting takeover targets for large biotech and…
Health care software maker Castlight Health launched its initial public offering (IPO) Friday morning, and "launch" is the right word. Shares have taken off, rising more than 162% in early trading.
Two analyst upgrades on Friday, a new CEO and a 33% increase in its stock price since November may be confirmation that Teva Pharmaceutical Industries is finally rebounding. Analysts think the stock could move…
In a new research report, the boutique firm Leerink highlights 10 top biotech names that are strong candidates for a partnership or acquisition. Any of these picks may be a great addition for portfolios…
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis, of the top health care stocks to buy now. Investors concerned about the toppy…
courtesy of NBN at German WikipediaMore than 30.2% of people in Kentucky were smokers in 2013. Barely behind at 29.9% were the residents of adjacent West Virginia. At the other end of the spectrum,…
Wikimedia CommonsShares of drug maker Pfizer Inc. (NYSE: PFE) were halted Wednesday afternoon at $32.29, down about 0.4% from the opening price. The company announced that its patent infringement case against a number of…
Shares of Zogenix fell as much as 26% on Wednesday after a rival pharmaceutical company said it will seek regulatory approval of a tamper-proof version of Zogenix's powerful new pain drug.